Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Literature DB >> 19211735

The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Richard Wells¹, Laurence Stensland, Jeffrey Vieira.

Abstract

Human cytomegalovirus (HCMV) infection of a cell containing latent Kaposi's sarcoma-associated herpesvirus (KSHV) results in the activation of KSHV lytic replication and the production of infectious virus. In this study, we examined the HCMV genes identified as having a role in the activation of HCMV early genes for their ability to activate KSHV lytic replication. It was found that the UL112-113 locus was able to activate the complete KSHV lytic cycle, while the UL122-123 locus, encoding the IE1 and IE2 proteins, known to be strong transactivators, did not.

Entities: Gene Species

Mesh：

Substances：
Viral Proteins

Year: 2009 PMID： 19211735 PMCID： PMC2668449 DOI： 10.1128/JVI.02241-08

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

45 in total

Review 1. The pleiotropic effects of Kaposi's sarcoma herpesvirus.

Authors: Thomas F Schulz
Journal: J Pathol Date: 2006-01 Impact factor: 7.996

2. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.

Authors: Jianjiang Ye; Duane Shedd; George Miller
Journal: J Virol Date: 2005-02 Impact factor: 5.103

3. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.

Authors: Chun Lu; Yi Zeng; Zan Huang; Li Huang; Chao Qian; Guixia Tang; Di Qin
Journal: Am J Pathol Date: 2005-01 Impact factor: 4.307

4. Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region).

Authors: Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Daniela Re; Giuseppe P Segoloni; Rossana Cavallo
Journal: Nephrol Dial Transplant Date: 2007-03-12 Impact factor: 5.992

5. Kaposi's sarcoma after liver transplantation.

Authors: Fabrizio Di Benedetto; Stefano Di Sandro; Nicola De Ruvo; Massimiliano Berretta; Michele Masetti; Roberto Montalti; Roberto Ballarin; Stefania Cocchi; Leonardo Potenza; Mario Luppi; Giorgio E Gerunda
Journal: J Cancer Res Clin Oncol Date: 2007-10-09 Impact factor: 4.553

6. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors: Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal: J Virol Date: 2007-10-10 Impact factor: 5.103

7. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors: Fuqu Yu; Jiaying Feng; Josephine N Harada; Sumit K Chanda; Shannon C Kenney; Ren Sun
Journal: FEBS Lett Date: 2007-06-29 Impact factor: 4.124

8. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.

Authors: Feng-Chun Ye; Fu-Chun Zhou; Jian-Ping Xie; Tao Kang; Whitney Greene; Kurt Kuhne; Xiu-Fen Lei; Qui-Hua Li; Shou-Jiang Gao
Journal: J Virol Date: 2008-02-27 Impact factor: 5.103

9. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.

Authors: Di Qin; Yi Zeng; Chao Qian; Zan Huang; Zhigang Lv; Lin Cheng; Shuihong Yao; Qiao Tang; Xiuying Chen; Chun Lu
Journal: Cell Microbiol Date: 2007-11-27 Impact factor: 3.715

10. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Authors: Fuqu Yu; Josephine N Harada; Helen J Brown; Hongyu Deng; Moon Jung Song; Ting-Ting Wu; Juran Kato-Stankiewicz; Christian G Nelson; Jeffrey Vieira; Fuyuhiko Tamanoi; Sumit K Chanda; Ren Sun
Journal: PLoS Pathog Date: 2007-03 Impact factor: 6.823

12 in total

1. Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase processivity factor in promoting DNA replication of human cytomegalovirus.

Authors: Young-Eui Kim; Jin-Hyun Ahn
Journal: J Virol Date: 2010-06-10 Impact factor: 5.103

2. Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.

Authors: Shinya Omoto; Edward S Mocarski
Journal: J Virol Date: 2013-05-29 Impact factor: 5.103

3. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors: Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal: Cancer Treat Res Date: 2019

4. A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication.

Authors: Kareni J Perez; Francisco Puerta Martínez; Ruth Cosme-Cruz; Neysa M Perez-Crespo; Qiyi Tang
Journal: J Virol Date: 2012-12-19 Impact factor: 5.103

5. Requirement of the N-terminal residues of human cytomegalovirus UL112-113 proteins for viral growth and oriLyt-dependent DNA replication.

Authors: Young-Eui Kim; Mi Young Park; Kyeong Jin Kang; Tae Hee Han; Chan Hee Lee; Jin-Hyun Ahn
Journal: J Microbiol Date: 2015-07-31 Impact factor: 3.422

6. Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes.

Authors: Bo Cheng; Francisco Puerta Martínez; Harutaka Katano; Qiyi Tang
Journal: J Clin Virol Date: 2009-09-01 Impact factor: 3.168

7. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.

Authors: Yen-Ju Chen; Wan-Hua Tsai; Yu-Lian Chen; Ying-Chieh Ko; Sheng-Ping Chou; Jen-Yang Chen; Su-Fang Lin
Journal: PLoS One Date: 2011-03-10 Impact factor: 3.240